Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization

Acta Ophthalmol. 2008 Feb;86(1):115-6. doi: 10.1111/j.1600-0420.2007.00977.x. Epub 2007 Aug 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Carcinoma, Adenoid Cystic / radiotherapy*
  • Humans
  • Injections
  • Male
  • Maxillary Sinus Neoplasms / radiotherapy*
  • Radiation Injuries / complications*
  • Retinal Neovascularization / drug therapy*
  • Retinal Neovascularization / etiology
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab